The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment Trials
Abstract
PURPOSE: We chose to examine the impact of socioeconomic factors on accrual to National Cancer Institute (NCI)–sponsored cancer treatment trials. PATIENTS AND METHODS: We estimated the geographic and demographic cancer burden in the United States and then identified 24,332 patients accrued to NCI-sponsored cancer treatment trials during a 12-month period. Next, we examined accrual by age, sex, geographic residence, health insurance status, health maintenance organization market penetration, several proxy measures of socioeconomic status, the availability of an oncologist, and the presence of a hospital with an approved multidisciplinary cancer program. RESULTS: Pediatric patients were accrued to clinical trials at high levels, whereas after adolescence, only a small percentage of cancer patients were enrolled onto clinical trials. There were few differences by sex. Black males as well as Asian-American and Hispanic adults were accrued to clinical trials at lower rates than white cancer patients of the same age. Overall, the highest observed accrual was in suburban counties. Compared with the United States population, patients enrolled onto clinical trials were significantly less likely to be uninsured and more like to have Medicare health insurance. Geographic areas with higher socioeconomic levels had higher levels of clinical trial accruals. The number of oncologists and the presence of approved cancer programs both were significantly associated with increased accrual to clinical trials. CONCLUSION: We must work to increase the number of adults who enroll onto trials, especially among the elderly. Ongoing partnership with professional societies may be an effective approach to strengthen accrual to clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Self-citationLandis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Socioeconomic Inequalities in Health: No Easy Solution
Adler, N. E. (1993) · JAMA · doi:10.1001/jama.1993.03500240084031 · Cited by 1,070
Representation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Self-citationWhy genes don't count (for racial differences in health)
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.11.1699 · Cited by 325
Schiffman, M., & Adrianza, E. (2000) · Acta Cytologica · doi:10.1159/000328554 · Cited by 252
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.11.1694 · Cited by 218
National cancer clinical trials: Children have equal access; adolescents do not
BLEYER, W., TEJEDA, H., MURPHY, S., ROBISON, L., ROSS, J., POLLOCK, B., SEVERSON, R., BRAWLEY, O., SMITH, M., & UNGERLEIDER, R. (1997) · Journal of Adolescent Health · doi:10.1016/s1054-139x(97)00110-9 · Cited by 207
Self-citationMultilocus Genotypes, a Tree of Individuals, and Human Evolutionary History
Mountain, J. L., & Cavalli-Sforza, L. L. (1997) · The American Journal of Human Genetics · doi:10.1086/515510 · Cited by 150
Cited by
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004) · JAMA · doi:10.1001/jama.291.22.2720 · Cited by 2,078
Bonevski, B., Randell, M., Paul, C., Chapman, K., Twyman, L., Bryant, J., Brozek, I., & Hughes, C. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-42 · Cited by 1,467
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., Tilburt, J., Baffi, C., Tanpitukpongse, T. P., Wilson, R. F., et al. (2008) · Cancer · doi:10.1002/cncr.23157 · Cited by 1,083
Fogel, D. B. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.08.001 · Cited by 1,035
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Lewis, J. H., Kilgore, M. L., Goldman, D. P., Trimble, E. L., Kaplan, R., Montello, M. J., Housman, M. G., & Escarce, J. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.010 · Cited by 1,031
Self-citationAre Racial and Ethnic Minorities Less Willing to Participate in Health Research?
Wendler, D., Kington, R., Madans, J., Wye, G. V., Christ-Schmidt, H., Pratt, L. A., Brawley, O. W., Gross, C. P., & Emanuel, E. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030019 · Cited by 854
Self-citationTalarico, L., Chen, G., & Pazdur, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.175 · Cited by 727
Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials
Townsley, C. A., Selby, R., & Siu, L. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.141 · Cited by 583
Loree, J. M., Anand, S., Dasari, A., Unger, J. M., Gothwal, A., Ellis, L. M., Varadhachary, G., Kopetz, S., Overman, M. J., & Raghav, K. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1870 · Cited by 570
Unger, J. M., Vaidya, R., Hershman, D. L., Minasian, L. M., & Fleury, M. E. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy221 · Cited by 570
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Muss, H. B., Berry, D. A., Cirrincione, C. T., Theodoulou, M., Mauer, A. M., Kornblith, A. B., Partridge, A. H., Dressler, L. G., Cohen, H. J., Becker, H. P., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810266 · Cited by 554
Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients with Cancer
Hamel, L. M., Penner, L. A., Albrecht, T. L., Heath, E., Gwede, C. K., & Eggly, S. (2016) · Cancer Control · doi:10.1177/107327481602300404 · Cited by 463
Adjuvant Chemotherapy in Older and Younger Women With Lymph Node–Positive Breast Cancer
Muss, H. B. (2005) · JAMA · doi:10.1001/jama.293.9.1073 · Cited by 418
Muss, H. B., Berry, D. A., Cirrincione, C., Budman, D. R., Henderson, I. C., Citron, M. L., Norton, L., Winer, E. P., & Hudis, C. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9710 · Cited by 339
Technological innovation and inequality in health
Glied, S., & Lleras-Muney, A. (2008) · Demography · doi:10.1353/dem.0.0017 · Cited by 304
Patient Income Level and Cancer Clinical Trial Participation
Unger, J. M., Hershman, D. L., Albain, K. S., Moinpour, C. M., Petersen, J. A., Burg, K., & Crowley, J. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.4553 · Cited by 290
Baquet, C. R., Commiskey, P., Daniel Mullins, C., & Mishra, S. I. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2005.12.001 · Cited by 289
Wheeler, S. B., Reeder-Hayes, K. E., & Carey, L. A. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0243 · Cited by 275
Unger, J. M., Hershman, D. L., Till, C., Minasian, L. M., Osarogiagbon, R. U., Fleury, M. E., & Vaidya, R. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa155 · Cited by 262
Fayter, D., McDaid, C., & Eastwood, A. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.12.013 · Cited by 112
Niranjan, S. J., Wenzel, J. A., Martin, M. Y., Fouad, M. N., Vickers, S. M., Konety, B. R., & Durant, R. W. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00970 · Cited by 62
Barriers and Challenges to Global Clinical Cancer Research
Seruga, B., Sadikov, A., Cazap, E. L., Delgado, L. B., Digumarti, R., Leighl, N. B., Meshref, M. M., Minami, H., Robinson, E., Yamaguchi, N. H., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0290 · Cited by 54
Recruiting Chinese Americans into cancer screening intervention trials: Strategies and outcomes
Wang, J. H.-Y., Sheppard, V. B., Liang, W., Ma, G. X., & Maxwell, A. E. (2014) · Clinical Trials · doi:10.1177/1740774513518849 · Cited by 34
Skinner, J. S., Fair, A. M., Holman, A. S., Boyer, A. P., & Wilkins, C. H. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00104 · Cited by 26
Monreal, I., Chappell, H., Kiss, R., Friedman, D. R., Akesson, J., Sae-Hau, M., Szumita, L., Halwani, A., & Weiss, E. S. (2025) · Military Medicine · doi:10.1093/milmed/usae441 · Cited by 6
Metadata
- Authors
- Sateren, W. B., Trimble, E. L., Abrams, J., Brawley, O., Breen, N., Ford, L., McCabe, M., Kaplan, R., Smith, M., Ungerleider, R., & Christian, M. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-04-15
- Volume
- 20
- Issue
- 8
- Pages
- 2109-2117
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2105940636
- Cited by
- 535
- References
- 19
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.